SCHEMBL3598248

SCHEMBL3598248

O=C(O)c1cc2ccc3cnccc3c2[nH]1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.62
HSD17B10 Q99714 3/20 0.62
ALDH1A1 P00352 2/20 0.62
MEN1 O00255 1/20 0.62
USP2 O75604 1/20 0.62
KMT2A Q03164 1/20 0.62
EIF4A3 P38919 2/20 0.44
APEX1 P27695 1/20 0.42
CDK4 P11802 1/20 0.41
CCND1 P24385 1/20 0.41
CDC7 O00311 1/20 0.41
KDM4E B2RXH2 5/20 0.40
DAO P14920 2/20 0.40
MAPT P10636 1/20 0.40
SRD5A2 P31213 1/20 0.40
CSNK2A1 P68400 2/20 0.40
AURKA O14965 1/20 0.40
DAPK3 O43293 1/20 0.40
JAK2 O60674 1/20 0.40
ROCK2 O75116 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30776674 0.81 ALDH1A1 (0.43) HPGDHSD17B10ALDH1A1MEN1USP2
SCHEMBL30779337 0.81 HPGD (0.47) HPGDHSD17B10ALDH1A1MEN1USP2
SCHEMBL30779338 0.81 HPGD (0.47) HPGDHSD17B10ALDH1A1MEN1USP2
SCHEMBL27074471 0.81 HPGD (0.47) HPGDHSD17B10ALDH1A1MEN1USP2
SCHEMBL27075711 0.81 ALDH1A1 (0.43) HPGDHSD17B10ALDH1A1MEN1USP2
SCHEMBL3598543 0.79 MMP13 (0.54) HPGDHSD17B10ALDH1A1MEN1KMT2A
SCHEMBL30797370 0.78 HPGD (0.47) HPGDHSD17B10ALDH1A1MEN1USP2
SCHEMBL27085692 0.78 HPGD (0.47) HPGDHSD17B10ALDH1A1MEN1USP2
SCHEMBL168527 0.77 DAO (0.58) HPGDHSD17B10ALDH1A1APEX1KDM4E
SCHEMBL29513389 0.77 HSD17B10 (1.00) HPGDHSD17B10ALDH1A1MEN1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2118102-B1 TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES NERVIANO MEDICAL SCIENCES SRL (IT) 2013-06-12 EP disclosed
US-8207180-B2 Tricyclic indoles and (4,5-dihydro) indoles NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-06-26 US disclosed
US-20100075998-A1 TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2010-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100075998-A1 TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES CDC7, CDK7, CDK17 HPGD 2745/4885HSD17B10 1587/4885ALDH1A1 2469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.